Lipase News and Research

RSS
Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Specific gene mutation may significantly reduce risk of heart attack

Specific gene mutation may significantly reduce risk of heart attack

Genetic errors may reduce heart attack risk, study finds

Genetic errors may reduce heart attack risk, study finds

Cells with higher fat content live longer than lean cells

Cells with higher fat content live longer than lean cells

Enzyme screening kits and samples global distribution agreement signed between Strem and Novozymes

Enzyme screening kits and samples global distribution agreement signed between Strem and Novozymes

Confirming nasogastric tube placement through an assay? An interview with Ian Fotheringham

Confirming nasogastric tube placement through an assay? An interview with Ian Fotheringham

Study identifies FGF21 protein as potential therapeutic agent for cardiovascular diseases, type 2 diabetes

Study identifies FGF21 protein as potential therapeutic agent for cardiovascular diseases, type 2 diabetes

Vanderbilt study offers a glimmer of hope to alcoholics suffering from depression

Vanderbilt study offers a glimmer of hope to alcoholics suffering from depression

TSRI scientists discover molecular ‘switch’ that could reduce nicotine addiction

TSRI scientists discover molecular ‘switch’ that could reduce nicotine addiction

UF researchers reveal link between chronic stress and fat metabolism

UF researchers reveal link between chronic stress and fat metabolism

Cholesterol essential for health, but also plays key role in longevity

Cholesterol essential for health, but also plays key role in longevity

Kanuma approved as first treatment for patients with LAL deficiency

Kanuma approved as first treatment for patients with LAL deficiency

Ingenza and Imperial researchers work together to improve nasogastric feeding tube placement

Ingenza and Imperial researchers work together to improve nasogastric feeding tube placement

New trial results show efficacy of novel enzyme-replacement therapy for genetic lipid disorder

New trial results show efficacy of novel enzyme-replacement therapy for genetic lipid disorder

Vascular side effects prevent first-line ponatinib use in chronic phase CML

Vascular side effects prevent first-line ponatinib use in chronic phase CML

Novartis announces FDA approval of Odomzo (sonidegib) 200 mg capsules for treatment of laBCC patients

Novartis announces FDA approval of Odomzo (sonidegib) 200 mg capsules for treatment of laBCC patients

Abide Therapeutics begins Phase 1a study of ABX-1431 investigational endocannabinoid system modulator

Abide Therapeutics begins Phase 1a study of ABX-1431 investigational endocannabinoid system modulator

Nutrition experts offer tips to employees working in sedentary environment

Nutrition experts offer tips to employees working in sedentary environment

MedImmune, AstraZeneca present encouraging results from new combination-focused immuno-oncology portfolio at ASCO 2015

MedImmune, AstraZeneca present encouraging results from new combination-focused immuno-oncology portfolio at ASCO 2015

Combination of nivolumab and ipilimumab drugs can improve outcomes in patients with advanced melanoma

Combination of nivolumab and ipilimumab drugs can improve outcomes in patients with advanced melanoma